4.7 Article

Early pregnancy loss in patients with polycystic ovary syndrome after IVM versus standard ovarian stimulation for IVF/ICSI

Journal

HUMAN REPRODUCTION
Volume 35, Issue 12, Pages 2763-2773

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/humrep/deaa200

Keywords

early pregnancy loss; miscarriage; IVM; ovarian stimulation; PCOS

Funding

  1. Cook Medical and Besins Healthcare

Ask authors/readers for more resources

STUDY QUESTION: Is the incidence of early pregnancy loss (EPL) in patients with polycystic ovary syndrome (PCOS) higher after IVM of oocytes than after ovarian stimulation (OS) for IVF/ICSI? SUMMARY ANSWER: Women with PCOS who are pregnant after fresh embryo transfer have a higher probability of EPL following IVM, but after frozen embryo transfer (FET), no significant difference in the incidence of EPL was observed following IVM compared to OS. WHAT IS KNOWN ALREADY: There is conflicting evidence in the current literature with regard to the risk of EPL after IVM of oocytes when compared with OS. Because of the limited sample size in previous studies, the use of different IVM systems and the possible bias introduced by patient characteristics and treatment type, firm conclusions cannot be drawn. STUDY DESIGN, SIZE, DURATION: This was a retrospective cohort study evaluating 800 women, with a diagnosis of infertility and PCOS as defined by Rotterdam criteria, who had a first positive pregnancy test after fresh or FET following IVM or OS between January 2010 and December 2017 in a tertiary care academic medical centre. PARTICIPANTS/MATERIALS, SETTING, METHODS: Pregnancies after non-hCG triggered IVM following a short course of highly purified human menopausal gonadotropin were compared with those after conventional OS. The primary outcome was EPL, defined as a spontaneous pregnancy loss before 10 weeks of gestation. MAIN RESULTS AND THE ROLE OF CHANCE: In total, 329 patients with a positive pregnancy test after IVM and 471 patients with a positive pregnancy test after OS were included. Women who were pregnant after IVM were younger (28.6 +/- 3.4 years vs 29.31 3.6 years, P= 0.005) and had higher serum anti-Mullerian hormone levels (11.5 +/- 8.1 ng/ml vs 7.2 +/- 4.1 ng/ml, P < 0.001) compared to those who were pregnant after OS. The distribution of PCOS phenotypes was significantly different among women in the IVM group compared to those in the OS group and women who were pregnant after OS had previously suffered EPL more often (28% vs 17.6%, P = 0.003). EPL was significantly higher after fresh embryo transfer following IVM compared to OS (57/122 (461%) vs 53/305 (17.4%), P < 0.001), while the results were comparable after FET (63/207 (30.4%) vs 60/166 (36.1%), respectively, P = 0.24). In the multivariate logistic regression analysis evaluating fresh embryo transfer cycles, IVM was the only independent factor (adjusted odds ratio (aOR) 4.24, 95% CI 2.44-7.37, P< 0.001)) significantly associated with increased odds of EPL. On the other hand, when the same model was applied to FET cycles, the type of treatment (IVM vs OS) was not significantly associated with EPL (aOR 0.73, 95% CI 0.43-1.25, P=0.25). LIMITATIONS, REASONS FOR CAUTION: The current data are limited by the retrospective nature of the study and the potential of bias due to unmeasured confounders. WIDER IMPLICATIONS OF THE FINDINGS: The increased risk of EPL after fresh embryo transfer following IVM may point towards inadequate endometrial development in IVM cycles. Adopting a freeze-all strategy after IVM seems more appropriate. Future studies are needed to ascertain the underlying cause of this observation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Genetics & Heredity

Installing oncofertility programs for breast cancer in limited versus optimum resource settings: Empirical data from 39 surveyed centers in Repro-Can-OPEN Study Part I & II

Mahmoud Salama, M. Lambertini, M. S. Christianson, Y. Jayasinghe, A. Anazodo, M. De Vos, F. Amant, C. Stern, L. Appiah, T. L. Woodard, R. A. Anderson, L. M. Westphal, R. E. Leach, K. A. Rodriguez-Wallberg, P. Patrizio, Teresa K. Woodruff

Summary: This study compared oncofertility practices for breast cancer in limited versus optimum resource settings and found higher scores in optimum resource settings, with commonly used methods including egg freezing and embryo freezing, while some new technologies are still in the early stages of clinical research.

JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2022)

Editorial Material Obstetrics & Gynecology

Should we stop screening for chronic endometritis?

Ezgi Darici, Christophe Blockeel, Shari Mackens

Summary: Chronic endometritis is an infectious or inflammatory process that disrupts the correct implantation of embryos. Its prevalence ranges from 2% to almost 60%, with a higher suspicion in women with recurrent early pregnancy loss and recurrent implantation failure. The impact of chronic endometritis on reproductive outcomes following IVF is uncertain due to the lack of convincing data showing improvement after diagnosis and treatment. This article critically evaluates current diagnostic methods, treatments, and patient populations for chronic endometritis.

REPRODUCTIVE BIOMEDICINE ONLINE (2023)

Article Obstetrics & Gynecology

Does the dose or type of gonadotropins affect the reproductive outcomes of poor responders undergoing modified natural cycle IVF (MNC-IVF)

P. Drakopoulos, F. Di Guardo, L. Boudry, S. Mackens, M. De Vos, G. Verheyen, H. Tournaye, C. Blockeel

Summary: The dose or type of gonadotropin does not affect the reproductive outcomes of poor responders undergoing MNC-IVF.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2022)

Article Obstetrics & Gynecology

Treatment algorithms for high responders: What we can learn from randomized controlled trials, real-world data and models

Panagiotis Drakopoulos, Yakoub Khalaf, Sandro C. Esteves, Nikolaos P. Polyzos, Sesh K. Sunkara, Daniel Shapiro, Botros Rizk, Hong Ye, Michael Costello, Yulia Koloda, Bruno Salle, Monica Lispi, Thomas D'Hooghe, Antonio La Marca

Summary: A high ovarian response refers to a greater number of follicles and/or oocytes compared to a normal response. It can be diagnosed before oocyte pick-up when there are >18-20 follicles ≥11-12 mm, or after oocyte pick-up when >18-20 oocytes have been retrieved. Women with a high response are at high risk of ovarian hyperstimulation syndrome (OHSS). Appropriate management strategies, such as individualized gonadotropin dosing, monitoring, and choice of protocols, can greatly reduce the risk of high response.

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2023)

Article Gastroenterology & Hepatology

Inflammatory bowel disease meets fertility: A physician and patient survey

Sophie Vieujean, Michel De Vos, Ferdinando D'Amico, Kristine Paridaens, Gaurang Daftary, Robert Dudkowiak, Laurent Peyrin-Biroulet, Silvio Danese

Summary: This study investigated the level of knowledge among health care professionals and patients about the impact of inflammatory bowel disease (IBD) on fertility. The results showed that health care professionals had good knowledge, while patients had poor knowledge. The study also revealed a lack of understanding among patients regarding the impact on sexual function and reproductive outcomes. The findings highlight the importance of improving education for both health care professionals and patients regarding fertility and sexual function in IBD.

DIGESTIVE AND LIVER DISEASE (2023)

Review Obstetrics & Gynecology

Outcomes of clinical in vitro maturation programs for treating infertility in hyper responders: a systematic review

Lan N. Vuong, Toan D. Pham, Tuong M. Ho, Michel De Vos

Summary: Oocyte in vitro maturation (IVM) has been considered as an alternative to conventional ovarian stimulation (COS) for subfertile women with polycystic ovary syndrome. Our systematic review found that the live birth rate after IVM was not significantly lower compared to COS, regardless of the stage of transferred embryos. While there may be a potentially higher rate of hypertensive disorders during pregnancy, there were no significant differences in obstetric or perinatal complications between IVM and COS.

FERTILITY AND STERILITY (2023)

Article Obstetrics & Gynecology

The combined effect of BMI and age on ART outcomes

Filipa Rafael, Maria Dias Rodrigues, Jose Bellver, Mariana Canelas-Pais, Nicolas Garrido, Juan A. Garcia-Velasco, Sergio Reis Soares, Samuel Santos-Ribeiro

Summary: For women with infertility and overweight/obesity, delaying infertility treatment to promote weight loss should consider female age. Substantial weight loss in a short period of time (3 months) seems to provide any benefit, particularly for women over 38 years old.

HUMAN REPRODUCTION (2023)

Article Obstetrics & Gynecology

Usability, accuracy, and cost-effectiveness of a medical software for early pregnancies: a retrospective study

F. Blavier, D. Grobet, C. Duflos, R. Rayssiguier, N. Ranisavljevic, M. Duport Percier, A. Rodriguez, C. Blockeel, S. Santos-Ribeiro, G. Faron, L. Gucciardo, F. Fuchs

Summary: Compared to the standard clinical approach, retrospective implementation of the new medical software in a gynaecological emergency unit was correlated with more accurate diagnosis and more cost-effective management.

HUMAN REPRODUCTION (2023)

Article Obstetrics & Gynecology

Individualized luteal phase support using additional oral dydrogesterone in artificially prepared frozen embryo transfer cycles: is it beneficial?

Shari Mackens, Francisca Pais, Panagiotis Drakopoulos, Samah Amghizar, Caroline Roelens, Lisbet Van Landuyt, Herman Tournaye, Michel De Vos, Christophe Blockeel

Summary: This retrospective cohort study aimed to investigate whether additional oral dydrogesterone supplementation improves reproductive outcomes in patients with low serum progesterone concentrations during frozen embryo transfer (FET) after artificial endometrial preparation. The study found that the live birth rate was comparable between patients who received additional oral dydrogesterone supplementation and those who continued with the routine protocol.

REPRODUCTIVE BIOMEDICINE ONLINE (2023)

Review Endocrinology & Metabolism

Individuals with numerical and structural variations of sex chromosomes: interdisciplinary management with focus on fertility potential

Anders Juul, Claus H. Gravholt, Michel De Vos, Ekaterina Koledova, Martine Cools

Summary: Diagnosis and management of individuals with differences of sex development (DSD) due to numerical or structural variations of sex chromosomes (NSVSC) is challenging. Girls with Turner syndrome (45X) may have varying phenotypic features. Individuals with 45,X/46,XY chromosomal mosaicism may have Turner syndrome-like features and short stature. Newborn screening for sex chromosome variations could be possible but requires further analysis. Comprehensive healthcare and fertility assessment are important for individuals with NSVSC.

FRONTIERS IN ENDOCRINOLOGY (2023)

Article Obstetrics & Gynecology

Aneuploidy in oocytes from women of advanced maternal age: analysis of the causal meiotic errors andimpact on embryo development

P. Verdyck, G. Altarescu, S. Santos-Ribeiro, C. Vrettou, U. Koehler, G. Griesinger, V Goossens, C. Magli, C. Albanese, M. Parriego, L. Coll, R. Ron-El, K. Sermon, J. Traeger-Synodinos

Summary: The study found that known chromosome segregation errors accounted for 90.4% of abnormal chromosome copy numbers in polar bodies of oocytes from women of advanced maternal age. These errors were associated with impaired embryo development.

HUMAN REPRODUCTION (2023)

Review Obstetrics & Gynecology

A fresh start for IVM: capacitating the oocyte for development using pre-IVM

Robert B. Gilchrist, Tuong M. Ho, Michel De Vos, Flor Sanchez, Sergio Romero, William L. Ledger, Ellen Anckaert, Lan N. Vuong, Johan Smitz

Summary: Recent advances in understanding oocyte biology and ovulation from animal studies have led to the development of biphasic IVM approaches, which involve pre-culturing immature oocytes before routine in vitro maturation. This novel procedure has the potential to significantly impact human ART practices. This review examines the scientific advances in ovarian biology, biphasic IVM procedures, and reports on outcomes from animal and clinical human data.

HUMAN REPRODUCTION UPDATE (2023)

Article Obstetrics & Gynecology

Fertility preservation in women with benign gynaecological conditions

Pietro Santulli, Christophe Blockeel, Mathilde Bourdon, Giovanni Coticchio, Alison Campbell, Michel De Vos, Kirsten Tryde Macklon, Anja Pinborg, Juan A. Garcia-Velasco

Summary: While there is extensive research on fertility preservation in women with malignant diseases, there is limited research on the role of fertility preservation in non-malignant conditions. This includes various benign gynaecological conditions that may affect reproductive potential. Currently, there is insufficient data to develop guidelines for clinical practice in fertility preservation for women with benign gynaecological conditions.

HUMAN REPRODUCTION OPEN (2023)

Article Obstetrics & Gynecology

Nature (almost) always prevails -challenging the status quo of artificial cycle frozen embryo transfers

Samuel Santos-Ribeiro, Catarina M. Godinho, Sergio Reis-Soares

Summary: Frozen embryo transfers (FET) are gaining popularity in assisted reproductive technology (ART) due to advancements in cryopreservation techniques and the 'freeze-all' strategy. The debate between artificial or natural cycles for FET preparation continues, but natural cycle FETs offer promising outcomes and increased convenience for patients.

REPRODUCTIVE BIOMEDICINE ONLINE (2023)

No Data Available